http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013011371-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_109e93b74241fe9ecb10a90c886e22bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d6c2b295ffc6dd0541e2ea071cadda8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea57db10fe6e572d4a54808447081e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66adb78b996337ceffdc69ce4163103e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-34
filingDate 2012-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66e31d1f5020f7234d291c95d2e7782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990087d6685cab956031730f56e5afd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f67644cce1eb1f4630fd8ce1ffacabe7
publicationDate 2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2013011371-A1
titleOfInvention ESTABLISHMENT OF PATIENT- OR PERSON- SPECIFIC CARDIAC MYOCYTE CELL LINES FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (iPSCs)
abstract A composition and method for generating patient- or person-specific proliferative and substantially pure cardiac myocyte cell lines from pluripotent stem cells (iPSCs) is described herein. The patient-specific cardiac myocyte cell lines of the present invention find applications in research, drug screening and autologous cell-based therapy. The method of the present invention is simple and reproducible and generates cardiac myocyte cells having high purities and proliferating capacities.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014127038-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017280089-A1
priorityDate 2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8058065-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66616222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID229455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226543156

Total number of triples: 41.